HARVARD MANAGEMENT CO INC - FULCRUM THERAPEUTICS INC ownership

FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 68 filers reported holding FULCRUM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
HARVARD MANAGEMENT CO INC ownership history of FULCRUM THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$1,129
-99.9%
341,972
-16.7%
0.11%
-9.8%
Q1 2023$1,170,535
-60.9%
410,7140.0%0.12%
-66.8%
Q4 2022$2,989,998
-10.0%
410,7140.0%0.37%
-10.2%
Q3 2022$3,323,000
+65.2%
410,7140.0%0.41%
+77.3%
Q2 2022$2,012,000
-79.3%
410,7140.0%0.23%
-76.2%
Q1 2022$9,713,000
+33.7%
410,7140.0%0.98%
+43.7%
Q4 2021$7,266,000
-37.3%
410,7140.0%0.68%
+0.4%
Q3 2021$11,586,000
+169.2%
410,7140.0%0.68%
+173.8%
Q2 2021$4,304,000
-11.0%
410,7140.0%0.25%
-8.1%
Q1 2021$4,838,000
+0.6%
410,7140.0%0.27%
+3.4%
Q4 2020$4,809,000
+47.7%
410,7140.0%0.26%
+45.8%
Q3 2020$3,257,000
-56.6%
410,7140.0%0.18%
-72.1%
Q2 2020$7,512,000
+53.2%
410,7140.0%0.64%
-16.4%
Q1 2020$4,904,000
-28.2%
410,7140.0%0.77%
+6.1%
Q4 2019$6,834,000
+150.6%
410,7140.0%0.72%
+184.6%
Q3 2019$2,727,000410,7140.25%
Other shareholders
FULCRUM THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
TRV GP III, LLC 3,962,202$19,415,0007.94%
TRV GP IV, LLC 2,343,154$11,481,0007.55%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 949$193,741,0002.02%
Logos Global Management LP 1,950,000$9,555,0001.75%
COWEN AND COMPANY, LLC 2,385,885$11,691,0001.13%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,355,624$16,443,0000.62%
ACUTA CAPITAL PARTNERS, LLC 200,000$980,0000.55%
RTW INVESTMENTS, LP 3,961,194$19,410,0000.50%
Parkman Healthcare Partners LLC 262,689$1,287,0000.47%
Deep Track Capital, LP 1,000,000$4,900,0000.32%
View complete list of FULCRUM THERAPEUTICS INC shareholders